BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home » Topics » Briefs » Regulatory actions

Regulatory actions
Regulatory actions RSS Feed RSS

Regulatory actions for April 2, 2026

April 2, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: A2 Biotherapeutics, Abbisko, Baebies, Bioxcel, Chiesi, Cogent, Orca, Ray, Restore Robotics, Serenity, Vertex.
Read More

Regulatory actions for April 1, 2026

April 1, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Ascendis, Elevar, Haemonetics, Medibeacon, Oculis, Polypid, Praxis, Sanofi, Scholar Rock.
Read More

Regulatory actions for March 31, 2026

March 31, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Anumana, Biogen, Boston Scientific, Bridgebio, Butterfly, Chiesi, Egetis, Eisai,Elevar, GSK, Merck, Nanoscope, Roche, Savara, SS Innovations, Sobi, Teva, Zymeworks.
Read More

Regulatory actions for March 31, 2026

March 31, 2026
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Deciphera, Eisai, GC, GSK, Immunitybio, Mars Bioimaging, Nuvation, Ono, OS Therapies, Pharming, Regeneron, Sanofi, Tarsus, Viatris.
Read More

Regulatory actions for March 30, 2026

March 30, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: ARS, Bavarian Nordic, Crinetics, Eisai, GSK, Johnson & Johnson, Medtronic, Novo Nordisk, Nuvation Bio, OS Therapies, Pharming, Rocket, Sanofi, Siga.
Read More

Regulatory actions for March 27, 2026

March 27, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 3D Systems, Agilent, Corcept, Deciphera, Deepecho, Denali, Fennec, GC Biopharma, Invivoscribe, Ono, Rhythm, Royal Philips, Soligenix.
Read More

Regulatory actions for March 26, 2026

March 26, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Anavex, Apotex, Ferring, Kallisio, OS Therapies, Pixee, Quoin, Triana.
Read More

Regulatory actions for March 25, 2026

March 25, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cephx, GE, Liviwell, Mars, Pharming, QT Imaging, Regeneron, Sanofi.
Read More

Regulatory actions for March 24, 2026

March 24, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: BMS, GSK, Immunitybio, Ionis, Tarsus, Viatris.
Read More

Regulatory actions for March 24, 2026

March 24, 2026
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Argo, Belief, Fujirebio, Gyre, H.U. Groupe, Peijia Medical, Sun, Telix.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 334 335 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing